Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin.

Depression has a reported mean prevalence of 24% in patients diagnosed with cancer. However, little systematic research on the efficacy of antidepressants in patients with cancer has been performed.
The efficacy and safety of mianserin were studied in 55 depressed women with breast cancer (stage I or II and without known metastases), in a randomised, double-blind, six-week, placebo-controlled study.
Statistically significant differences in the decrease in score from baseline on the Hamilton Rating Scale for Depression and the number of responders, favouring mianserin, were present after 28 and 42 days of treatment. Significantly more placebo-treated patients prematurely terminated the study due to lack of efficacy while the safety profile of mianserin was similar to that of placebo.
Treatment with mianserin resulted in a significant improvement in depressive symptoms in cancer patients, and was well tolerated.
AuthorsK van Heeringen, M Zivkov
JournalThe British journal of psychiatry : the journal of mental science (Br J Psychiatry) Vol. 169 Issue 4 Pg. 440-3 (Oct 1996) ISSN: 0007-1250 [Print] ENGLAND
PMID8894194 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Antidepressive Agents, Second-Generation
  • Mianserin
  • Adult
  • Aged
  • Antidepressive Agents, Second-Generation (adverse effects, therapeutic use)
  • Breast Neoplasms (pathology, psychology)
  • Depressive Disorder (diagnosis, drug therapy, psychology)
  • Double-Blind Method
  • Female
  • Humans
  • Mianserin (adverse effects, therapeutic use)
  • Middle Aged
  • Neoplasm Staging
  • Personality Inventory
  • Sick Role
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: